EntryPoint Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

EntryPoint Capital’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,795	Closed	-$154K	–	1761
2024 Q1	$154K	Sell	9,795 -775	-7%	-$11.9K	0.14%	207
2023 Q4	$170K	Buy	+10,570	New	+$135K	0.16%	140

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

EntryPoint Capital's DCPH Position: Q2 2024 in Review

EntryPoint Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 9,795 shares — an estimated $154K sold.

EntryPoint Capital first reported a position in DCPH in Q4 2023 and held it in 2 quarters. The position peaked at $170K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

EntryPoint Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
EntryPoint Capital sold 9,795 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $154K.
EntryPoint Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
EntryPoint Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $170K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.